Alector's AL002 misses primary endpoint in Alzheimer's trial. BofA downgrades stock, cuts price target, and highlights near-term challenges.
Daiwa analyst Narumi Nakagiri downgraded AbbVie (ABBV) to Neutral from Outperform with an $180 price target Don't Miss our Black Friday ...
South Korean Leader’s Fate Is in Doubt as Lawmakers Move to Impeach Him The effort to remove President Yoon Suk Yeol reflected fury over his declaration of martial law. He lifted the order ...
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...
Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...
Cunard Line has announced its Queen Elizabeth will get a makeover in 2025, setting the stage for its first-ever full Caribbean season and an Alaska debut.